Guangzhou RiboBio Co., Ltd. operates a CDMO/CMO platform (RiboPharm) that is Asia's largest GMP oligonucleotide API manufacturer, with over 20,000 sqm of planned production area. The company provides comprehensive oligonucleotide drug discovery, process and analytical development, CMC services, API production, and aseptic fill-finish, serving global pharmaceutical companies in bringing nucleic acid drugs from development to market.
Oligonucleotide API manufacturing, nucleic acid drug CDMO, RNAi, lncRNA, miRNA, aseptic filling, CMC services
1 site worldwide
No certifications on file yet.
No reviews available yet.
No documents available.